These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22238119)

  • 1. Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    Han B; Cui D; Jing Y; Hong Y; Xia S
    World J Urol; 2012 Dec; 30(6):861-7. PubMed ID: 22238119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    Han B; Cui D; Jing Y; Hong Y; Xia S
    World J Urol; 2014 Feb; 32(1):149-55. PubMed ID: 24616912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-β expression and pharmacological targeting in bladder cancer.
    Kauffman EC; Robinson BD; Downes M; Marcinkiewicz K; Vourganti S; Scherr DS; Gudas LJ; Mongan NP
    Oncol Rep; 2013 Jul; 30(1):131-8. PubMed ID: 23612777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection.
    Muramaki M; Miyake H; Terakawa T; Kumano M; Sakai I; Fujisawa M
    Urol Oncol; 2012; 30(2):161-6. PubMed ID: 20451421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.
    Santos LL; Amaro T; Pereira SA; Lameiras CR; Lopes P; Bento MJ; Oliveira J; Criado B; Lopes CS
    Eur J Surg Oncol; 2003 Feb; 29(1):74-80. PubMed ID: 12559081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of N-E cadherin switch as an independent predictive parameter of bladder cancer survival outcomes].
    Cui D; Han BM; Jing YF; Xia SJ
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(6):380-3. PubMed ID: 22490896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features.
    Luo HL; Sung MT; Tsai EM; Lin CS; Lee NL; Chung YH; Chiang PH
    Sci Rep; 2016 Apr; 6():24263. PubMed ID: 27052470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Significance of Estrogen Receptor
    Sato N; Ise K; Hata S; Yamashita S; Ito A; Sasano H; Nakamura Y
    Pathol Oncol Res; 2021; 27():589649. PubMed ID: 34257538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
    Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
    Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
    Bernardo C; Monteiro FL; Direito I; Amado F; Afreixo V; Santos LL; Helguero LA
    Front Endocrinol (Lausanne); 2021; 12():684140. PubMed ID: 34690921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
    Teng J; Wang ZY; Jarrard DF; Bjorling DE
    Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.
    Santi R; Cai T; Nobili S; Galli IC; Amorosi A; Comperat E; Nesi G
    Virchows Arch; 2018 Apr; 472(4):605-613. PubMed ID: 29525824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Liu B; Miyake H; Nishikawa M; Fujisawa M
    Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer.
    Abufaraj M; Shariat SF; Haitel A; Moschini M; Foerster B; Chłosta P; Gust K; Babjuk M; Briganti A; Karakiewicz PI; Albrecht W
    Urol Oncol; 2017 May; 35(5):264-271. PubMed ID: 28214283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer.
    Nakopoulou L; Zervas A; Gakiopoulou-Givalou H; Constantinides C; Doumanis G; Davaris P; Dimopoulos C
    Anticancer Res; 2000; 20(6B):4571-8. PubMed ID: 11205306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence.
    Izumi K; Ito Y; Miyamoto H; Miyoshi Y; Ota J; Moriyama M; Murai T; Hayashi H; Inayama Y; Ohashi K; Yao M; Uemura H
    Oncotarget; 2016 Mar; 7(12):14153-60. PubMed ID: 26885620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder.
    Yu HJ; Chang YH; Pan CC
    Histopathology; 2013 Apr; 62(5):788-98. PubMed ID: 23425286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.
    Ide H; Inoue S; Miyamoto H
    PLoS One; 2017; 12(3):e0174746. PubMed ID: 28362839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.